Skip to main content
Search form
Search
Medicines for Malaria Venture
Developing antimalarials to save lives
Research & Development
MMV's pipeline of antimalarial drugs
R&D areas of work
Next-generation medicines
Products for key populations
Working with regulators
Information for scientists
Malaria online course
Global health compound design webinars
Call for proposals
TPPs & TCPs
Learning resources for scientists
Project of the year award
Computational chemistry
R&D challenges
Access
Products & projects
Antimalarial drug availability
Areas of work
Supporting introduction
Enhancing reach
Informing R&D
Gathering market intelligence
Antimalarial drug toolkits
Artesunate injection dosage & administration
Artesunate rectal capsules tool kit
Seasonal Malaria Chemoprevention tool kit
Access challenges
Partnering
The PDP model
Our partner network
Our donors
Current donors
Past donors
Donate to MMV
Intellectual property rights (IPR)
Clinical centre partners by country
Our impact
Milestones
Malaria stories from the field
Antimalarial drugs for children
Gender equity
Global health security
Antimicrobial resistance to antimalarials
Malaria and COVID-19
About us
What we do
An overview of our work
Our strategic focus
Our history
People & governance
Staff bios
Staff interviews
Board of Directors
MMV North America Board
Expert Scientific Advisory Committee
Access & Product Management Advisory Committee
Global Safety Board
Work with us
Jobs
RFPs/RFIs
Policies
Diversity at MMV
Funding and expenditure
FAQs
Contact us
Malaria & medicines
Definitions and symptoms
5 species of
Plasmodium
parasites
Lifecycle of malaria parasite
Malaria facts & statistics
Malaria treatment
History of antimalarial drugs
Newsroom
News & Press Releases
Audio
Media interviews
Speaking of Malaria podcast
Films
Infographics
Interviews
Image slideshows
Publications
Events
MMV Open
The Global Health Priority Box
About the Global Health Priority Box
Supporting information
Request the Global Health Priority Box
Terms & conditions
Malaria
Libre
Malaria
Libre
open innovation platform
Participate in Malaria
Libre
Malaria
Libre
data repository
MMVSola
About MMVSola
Pandemic Response Box
About the Pandemic Response Box
Request the Pandemic Response Box
Supporting information
Terms & conditions
COVID Box
About the COVID Box
Supporting information
COVID Box terms and conditions
Archived projects
Pathogen Box
Malaria Box
MMV Open Team
Contact us
Home
Newsroom
News
News
Filter
All
R&D
Donors
General
Open source
Partner
Access & product management
All
R&D
Donors
General
Open source
Partner
Access & product management
308 found
MMV and partners handover SMS for Life in Tanzania to Government
07 Jan 2013
Malaria funding falls short by half
18 Dec 2012
MMV to advance WHO-TDR’s pioneering studies on intrarectal artesunate
14 Dec 2012
Focusing on malaria drug discovery
13 Dec 2012
UNITAID awards MMV-led consortium up to US$ 34 million
11 Dec 2012
Eurartesim® awarded MMV Project of the Year 2011
12 Nov 2012
Drawing attention to malaria
25 Oct 2012
Momentum builds for neglected diseases drug discovery
21 Sep 2012
Improving safety for antimalarial drugs
31 Aug 2012
New medicine for relapsing malaria being evaluated in four countries
27 Aug 2012
Eurartesim® reaches Cambodia
19 Jul 2012
MMV supports Asia Pacific malaria forum
19 Jul 2012
MMV and the European Bioinformatics Institute establish one-stop shop for malaria drug data
13 Jul 2012
Scaling-up access to life-saving antimalarials in Nigeria
11 Jul 2012
OZ439 clears the first clinical development hurdle
11 Jul 2012
Pyronaridine/artesunate included in the list of WHO prequalified medicines
15 May 2012
MMV’s Chief Scientific Officer elected to Academy of Medical Sciences
10 May 2012
Former MMV ESAC member receives Gairdner Foundation award
17 Apr 2012
Ian Bathurst Global Health Travel Awards
02 Apr 2012
Sharing the fruits of science to accelerate drug discovery
22 Mar 2012
Rewarding innovative ideas
22 Mar 2012
Double commendation for MMV ESAC member
15 Mar 2012
Condolence message
10 Feb 2012
Yvonne Chaka Chaka becomes first African woman to receive WEF's Crystal Award
26 Jan 2012
The year in review
16 Jan 2012
Do you have an idea that could revolutionize malaria drug discovery?
12 Jan 2012
Former MMV ESAC member awarded Queen’s New Year Honour
03 Jan 2012
U.N. Special Envoy for Malaria, Ray Chambers, and RBM Executive Director, Professor Awa Coll-Seck, awarded “UNCA Citizen of the Year Award”
14 Dec 2011
World Malaria Report 2011 highlights fragile progress
13 Dec 2011
MMV delivers testimony to US congress
05 Dec 2011
Eurartesim® receives stringent regulatory approval from the EMA
10 Nov 2011
SMS for Life wins WSJ Innovation Award 2011
31 Oct 2011
MMV Symposium at EDCTP
20 Oct 2011
Launch of the CAPSS Plus Pilot in Uganda
30 Sep 2011
Chinese scientist wins award for life-saving discovery of artemisinin
23 Sep 2011
MMV ESAC member receives accolade for malaria research
22 Aug 2011
Pyramax® edges closer to patients
19 Aug 2011
The Ian Bathurst Sponsorship Programme
07 Jul 2011
MMV holds malaria session at The World Conference of Science Journalists
01 Jul 2011
MMV loses a dear colleague and friend
28 Jun 2011
DHODH awarded MMV’s Project of the Year 2010
01 Jun 2011
Ray Chambers takes over from Baroness Chalker as MMV's Chairman
01 Jun 2011
Press briefing to mark World Malaria Day
21 Apr 2011
Ray Chambers among TIME's Top 100
21 Apr 2011
MMV’s CEO delivers strong message at Oslo malaria conference
13 Apr 2011
WHO: Low quality drugs continue to afflict Africa
25 Feb 2011
G-FINDER 2010: Good news with a twist in the tail for PDPs
18 Feb 2011
MMV signs MoU with ALMA at the African Union Summit
03 Feb 2011
Ground-breaking trial underway to protect pregnant women from malaria
28 Jan 2011
WHO report calls for urgent action to protect malaria therapies
12 Jan 2011
Global plan for artemisinin resistance containment (GPARC)
11 Jan 2011
MMV's new CEO comes on board
05 Jan 2011
Letter from the CEO
22 Dec 2010
World Malaria Report shows scale-up of control activities is paying-off
14 Dec 2010
WHO report calls for greater vigilance to allow early detection of artemisinin resistance
18 Nov 2010
Conclusive win of artesunate over quinine
08 Nov 2010
MMV-supported artesunate for injection receives WHO prequalification
08 Nov 2010
MMV announces new Chairman of the Board effective 2011
21 Oct 2010
Germany to give €20M to neglected disease research
20 Oct 2010
MMV appoints new CEO
12 Oct 2010
Pages
« first
‹ previous
1
2
3
4
5
6
next ›
last »